Page 42 - 《中国药房》2022年13期

参考文献 chemical characteristics of a nanoliposome-based system for
[ 1 ] HU J H，SHI J L，GAO Y Q，et al. 808 nm near-infrared dual drug delivery[J]. Nanoscale Res Lett，2018，13（1）：101.
light-excited UCNPs@mSiO2-Ce6-GPC3 nanocomposites [17] LIANG T S，GUAN R F，QUAN Z，et al. Cyanidin-3-O-
for photodynamic therapy in liver cancer[J]. Int J Nano- glucoside liposome：preparation via a green method and
med，2019，14：10009-10021. antioxidant activity in GES-1 cells[J]. Food Res Int，2019，
[ 2 ] XU C Z，ZHANG W，ZHANG X N，et al. Coupling func- 125：108648.
tion of cyclin-dependent kinase 2 and septin2 in the pro- [18] DE M BARBOSA R，RIBEIRO L N M，CASADEI B R，
motion of hepatocellular carcinoma[J]. Cancer Sci，2019， et al. Solid lipid nanoparticles for dibucaine sustained
110（2）：540-549. release[J]. Pharmaceutics，2018，10（4）：E231.
[ 3 ] YOON S M，RYOO B Y，LEE S J，et al. Efficacy and safety [19] AHMED K S，HUSSEIN S A，ALI A H，et al. Liposome：
of transarterial chemoembolization plus external beam composition，characterisation，preparation，and recent in-
radiotherapy vs. sorafenib in hepatocellular carcinoma novation in clinical applications[J]. J Drug Target，2019，
with macroscopic vascular invasion：a randomized clinical 27（7）：742-761.
trial[J]. JAMA Oncol，2018，4（5）：661-669. [20] 刘骏，罗莹，张婧，等.白头翁皂苷B4长循环脂质体的处
[ 4 ] RIMASSA L，DANESI R，PRESSIANI T，et al. Manage- 方优化与评价[J].中国新药杂志，2021，30（16）：1524-1529.
ment of adverse events associated with tyrosine kinase in- [21] HAO F，YAN X P. Nano-sized zeolite-like metal-organic
hibitors：improving outcomes for patients with hepatocel- frameworks induced hematological effects on red blood
lular carcinoma[J]. Cancer Treat Rev，2019，77：20-28. cell[J]. J Hazard Mater，2022，424：127353.
[ 5 ] CAO M R，LI Q，LIU Z L，et al. Harmine induces apoptosis [22] MIN Y，KIM M J，LEE S N，et al. Inhibition of TRAF6
in HepG2 cells via mitochondrial signaling pathway[J]. ubiquitin-ligase activity by PRDX1 leads to inhibition of
Hepatobiliary Pancreat Dis Int，2011，10（6）：599-604. NFKB activation and autophagy activation[J]. Autophagy，
[ 6 ] ZHU Y G，LV Y X，GUO C Y，et al. Harmine inhibits the 2018，14（8）：1347-1358.
proliferation and migration of glioblastoma cells via the [23] QIN J L，ZHONG Z Y，MA J. Biomimetic synthesis of hy-
FAK/AKT pathway[J]. Life Sci，2021，270：119112. brid hydroxyapatite nanoparticles using nanogel template
[ 7 ] ZONG W X，RABINOWITZ J D，WHITE E. Mitochon- for controlled release of bovine serum albumin[J]. Mater
dria and cancer[J]. Mol Cell，2016，61（5）：667-676. Sci Eng C Mater Biol Appl，2016，62：377-383.
[ 8 ] BURKE P J. Mitochondria，bioenergetics and apoptosis in [24] YU H，JIN F Y，LIU D，et al. ROS-responsive nano-drug
cancer[J]. Trends Cancer，2017，3（12）：857-870. delivery system combining mitochondria-targeting ceria
[ 9 ] JIN H Y，HE Y，ZHAO P F，et al. Targeting lipid metabo-
nanoparticles with atorvastatin for acute kidney injury[J].
lism to overcome EMT-associated drug resistance via inte- Theranostics，2020，10（5）：2342-2357.
grin β 3/FAK pathway and tumor-associated macrophage [25] JIANG L，LI L，HE X D，et al. Overcoming drug-resistant
repolarization using legumain-activatable delivery[J].
lung cancer by paclitaxel loaded dual-functional lipo-
Theranostics，2019，9（1）：265-278. somes with mitochondria targeting and pH-response[J].
[10] YE Z，GUO C L，SHEN W Z，et al. Clinicopathologic sig- Biomaterials，2015，52：126-139.
nificance of Legumain overexpression in cancer：a systema-
tic review and meta-analysis[J]. Sci Rep，2015，5：16599. [26] GUO W F，GAO X N，ZHAN R H，et al. Tricolor imaging
of MMPs to investigate the promoting roles of inflamma-
[11] ZHAO T，ZHOU H，LEI L，et al. A new tandem peptide
modified liposomal doxorubicin for tumor“ecological tion on invasion and migration of tumor cells[J]. Talanta，
2021，222：121525.
therapy”[J]. Nanoscale，2020，12（5）：3359-69
[27] VILLANUEVA A. Hepatocellular carcinoma[J]. N Engl J
[12] YAMADA Y，SATRIALDI，HIBINO M，et al. Power of
mitochondrial drug delivery systems to produce innovative Med，2019，380（15）：1450-1462.
nanomedicines[J]. Adv Drug Deliv Rev，2020，154-155. [28] O’DWYER J，MURPHY R，GONZÁLEZ-VÁZQUEZ A，
[13] LI J，LI L，LV Y，et al. The construction of the novel mag- et al. Translational studies on the potential of a VEGF
nanoparticle-loaded hyaluronic acid hydrogel[J]. Pharma-
netic prodrug Fe3O4@DOX and its antagonistic effects on
hepatocarcinoma with low toxicity[J]. RSC Adv，2020，10 ceutics，2021，13（6）：779.
（48）：28965-28974. [29] ANWANWAN D，SINGH S K，SINGH S，et al. Challenges
[14] 唐小慧，木尼热·库尔班，焦敏，等.转铁蛋白修饰的去氢 in liver cancer and possible treatment approaches[J]. Bio-
骆驼蓬碱磁纳米脂质体的制备及抑瘤效果评价[J].中国 chim Biophys Acta Rev Cancer，2020，1873（1）：188314.
药学杂志，2018，53（11）：900-905. [30] LIU C Y，YANG S S，WANG K L，et al. Alkaloids from
[15] LIU X L，DONG X，YANG S C，et al. Biomimetic liposo- traditional Chinese medicine against hepatocellular carci-
mal nanoplatinum for targeted cancer chemophototherapy noma[J]. Biomed Pharmacother，2019，120：109543.
[J]. Adv Sci（Weinh），2021，8（8）：2003679. （收稿日期：2022-03-01 修回日期：2022-04-22）
[16] NAM J H，KIM S Y，SEONG H. Investigation on physico- （编辑：舒安琴）

·1572 · China Pharmacy 2022 Vol. 33 No. 13 中国药房 2022年第33卷第13期